These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 23593253

  • 1. Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.
    Kantele A, Pakkanen SH, Karttunen R, Kantele JM.
    PLoS One; 2013; 8(4):e60583. PubMed ID: 23593253
    [Abstract] [Full Text] [Related]

  • 2. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH, Kantele JM, Savolainen LE, Rombo L, Kantele A.
    Vaccine; 2015 Jan 09; 33(3):451-8. PubMed ID: 25433216
    [Abstract] [Full Text] [Related]

  • 3. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH, Kantele JM, Herzog C, Kantele A.
    Vaccine; 2014 Jan 23; 32(5):544-51. PubMed ID: 24342246
    [Abstract] [Full Text] [Related]

  • 4. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH, Kantele JM, Kantele A.
    Vaccine; 2012 Sep 14; 30(42):6047-53. PubMed ID: 22858557
    [Abstract] [Full Text] [Related]

  • 5. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A, Pakkanen SH, Siitonen A, Karttunen R, Kantele JM.
    Vaccine; 2012 Nov 26; 30(50):7238-45. PubMed ID: 23084770
    [Abstract] [Full Text] [Related]

  • 6. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
    Pakkanen SH, Kantele JM, Kantele A.
    Scand J Immunol; 2014 Mar 26; 79(3):222-9. PubMed ID: 24383914
    [Abstract] [Full Text] [Related]

  • 7. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
    Wang JY, Noriega FR, Galen JE, Barry E, Levine MM.
    Infect Immun; 2000 Aug 26; 68(8):4647-52. PubMed ID: 10899868
    [Abstract] [Full Text] [Related]

  • 8. Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.
    Xiong K, Zhu C, Chen Z, Zheng C, Tan Y, Rao X, Cong Y.
    Front Cell Infect Microbiol; 2017 Aug 26; 7():135. PubMed ID: 28484685
    [Abstract] [Full Text] [Related]

  • 9. Specific and Cross-reactive Plasmablast Response in Humans after Primary and Secondary Immunization with Vi Capsular Polysaccharide Typhoid Vaccine.
    Pakkanen SH, Kantele JM, Rombo L, Kantele A.
    Scand J Immunol; 2017 Oct 26; 86(4):207-215. PubMed ID: 28675263
    [Abstract] [Full Text] [Related]

  • 10. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.
    Wahid R, Pasetti MF, Maciel M, Simon JK, Tacket CO, Levine MM, Sztein MB.
    Clin Immunol; 2011 Feb 26; 138(2):187-200. PubMed ID: 21146460
    [Abstract] [Full Text] [Related]

  • 11. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
    Tacket CO, Losonsky G, Taylor DN, Baron LS, Kopecko D, Cryz S, Levine MM.
    J Infect Dis; 1991 Apr 26; 163(4):901-4. PubMed ID: 2010645
    [Abstract] [Full Text] [Related]

  • 12. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM.
    J Infect Dis; 2004 Aug 01; 190(3):565-70. PubMed ID: 15243933
    [Abstract] [Full Text] [Related]

  • 13. Oral Typhoid Vaccination With Live-Attenuated Salmonella Typhi Strain Ty21a Generates Ty21a-Responsive and Heterologous Influenza Virus-Responsive CD4+ and CD8+ T Cells at the Human Intestinal Mucosa.
    Pennington SH, Thompson AL, Wright AK, Ferreira DM, Jambo KC, Wright AD, Faragher B, Gilmour JW, Gordon SB, Gordon MA.
    J Infect Dis; 2016 Jun 01; 213(11):1809-19. PubMed ID: 26810369
    [Abstract] [Full Text] [Related]

  • 14. IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model.
    Dahora LC, Jin C, Spreng RL, Feely F, Mathura R, Seaton KE, Zhang L, Hill J, Jones E, Alam SM, Dennison SM, Pollard AJ, Tomaras GD.
    Front Immunol; 2019 Jun 01; 10():2582. PubMed ID: 31781100
    [Abstract] [Full Text] [Related]

  • 15. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
    Wahid R, Simon R, Zafar SJ, Levine MM, Sztein MB.
    Clin Vaccine Immunol; 2012 Jun 01; 19(6):825-34. PubMed ID: 22492745
    [Abstract] [Full Text] [Related]

  • 16. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    Hart PJ, O'Shaughnessy CM, Siggins MK, Bobat S, Kingsley RA, Goulding DA, Crump JA, Reyburn H, Micoli F, Dougan G, Cunningham AF, MacLennan CA.
    PLoS One; 2016 Jun 01; 11(1):e0145945. PubMed ID: 26741681
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines.
    Kantele A, Arvilommi H, Kantele JM, Rintala L, Mäkelä PH.
    Microb Pathog; 1991 Feb 01; 10(2):117-26. PubMed ID: 1890950
    [Abstract] [Full Text] [Related]

  • 18. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
    Darton TC, Jones C, Blohmke CJ, Waddington CS, Zhou L, Peters A, Haworth K, Sie R, Green CA, Jeppesen CA, Moore M, Thompson BA, John T, Kingsley RA, Yu LM, Voysey M, Hindle Z, Lockhart S, Sztein MB, Dougan G, Angus B, Levine MM, Pollard AJ.
    PLoS Negl Trop Dis; 2016 Aug 01; 10(8):e0004926. PubMed ID: 27533046
    [Abstract] [Full Text] [Related]

  • 19. Age-Associated Heterogeneity of Ty21a-Induced T Cell Responses to HLA-E Restricted Salmonella Typhi Antigen Presentation.
    Rudolph ME, McArthur MA, Magder LS, Barnes RS, Chen WH, Sztein MB.
    Front Immunol; 2019 Aug 01; 10():257. PubMed ID: 30886613
    [Abstract] [Full Text] [Related]

  • 20. Vaccines for preventing typhoid fever.
    Milligan R, Paul M, Richardson M, Neuberger A.
    Cochrane Database Syst Rev; 2018 May 31; 5(5):CD001261. PubMed ID: 29851031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.